Genomics

Dataset Information

0

Polydextrose fermentation metabolite effect on Caco-2 colon cancer cells


ABSTRACT: Analysis of non-differentiated Caco-2 intestinal epithelial cell line treated with polydextrose fermentation metabolites fermented for 48 hours in 4-stage in vitro colon simulator, in which the conditions mimic the human proximal, ascending, transverse and distal colon in sequence , as well as with medium, 100 mM NaCl and 5 mM butyrate. Polydextrose, a soluble fiber fermented in colon, was fermented with the in vitro colon simulator in three amounts of 0%, 1% and 2%. Results provide insight into the mechanisms underlying colon cancer cells and a comparison of a complex fiber metabolome to 5 mM butyrate and 100 mM NaCl. Furthermore, the results give insight of dosage effect of increasing the concentration of fiber. High level of dietary fiber has been epidemiologically linked to protection against the risk for developing colon cancer. The mechanisms of this protection are not clear. Fermentation of dietary fiber in the colon results in production of for example butyrate that has drawn attention as a chemopreventive agent. Polydextrose, a soluble fiber that is only partially fermented in colon, was fermented in an in vitro colon simulator, in which the conditions mimic the human proximal, ascending, transverse and distal colon in sequence. The subsequent fermentation metabolome were applied on colon cancer cells, and the gene expression changes studied. Polydextrose fermentation down-regulated classes linked with cell cycle, and affected number of metabolically active cells. Further, up-regulated effects on classes linked with apoptosis implicate that polydextrose fermentation plays a role in induction of apoptosis in colon cancer cells. The up-regulated genes involved also key regulators of lipid metabolism, such as PPARg and PGC-1α. These results offer hypotheses for the mechanisms of two health benefits linked with consumption of dietary fiber, reducing risk of development of colon cancer, and dyslipidemia.

ORGANISM(S): Homo sapiens

PROVIDER: GSE28792 | GEO | 2011/04/22

SECONDARY ACCESSION(S): PRJNA138827

REPOSITORIES: GEO

Similar Datasets

| E-GEOD-28792 | biostudies-arrayexpress
2021-06-01 | GSE163055 | GEO
2017-09-08 | GSE87525 | GEO
| E-GEOD-59494 | biostudies-arrayexpress
2022-02-07 | GSE195578 | GEO
2022-02-15 | PXD008149 | Pride
2020-08-25 | GSE147022 | GEO
2015-05-26 | GSE59494 | GEO
| PRJNA515739 | ENA
2013-09-11 | GSE50728 | GEO